Hatta et al examine whether ramelteon, a melatonin agonist, is effective for the prevention of delirium. See also the invited commentary by de Rooij et al.
Allsop et al evaluate the safety and efficacy of nabiximols treating cannabis withdrawal with use of a 6-day regimen of nabiximols or placebo with standardized psychosocial interventions during a 9-day admission.
This pharmacoepidemiology study uses Medicare Part D data to describe the use of buprenorphine-naloxone in the United States in 2013.
This randomized clinical trial compares the effects of adjunctive raloxifene with antipsychotic therapy vs antipsychotics alone on illness severity in women with refractory schizophrenia.
This randomized clinical trial examines the relative efficacy of weight-adjusted d-cycloserine (25 or 50 mg) vs placebo augmentation of cognitive behavior therapy for youth with obsessive-compulsive disorder and assesses if concomitant antidepressant medication moderated effects.
This randomized clinical trial examines whether d-cycloserine augments cognitive behavioral therapy in the treatment of obsessive-compulsive disorder (OCD) and whether concomitant use of antidepressants moderates the effects of d-cycloserine.